At Angelini Pharma, we work every day to grow as a leading Pharma Company that makes a difference in patients’ life. Since 1919. We aim at becoming a leading European player, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies. We pledge to successfully develop distinctive treatments for CNS and Mental Health disorders while preserving our leading position in the Consumer Health segment. Angelini Pharma is part of Angelini Industries. Social media privacy notice: https://bit.ly/socialmediaprivacynotice
15
Total Investments
15
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Angelini Ventures
Recent Investments (15)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed | •••••• | Dec 2025 | |
| Seed | •••••• | Dec 2025 | |
| Series A | •••••• | Oct 2025 | |
| Series B | •••••• | May 2025 | |
| Series A | •••••• | Mar 2025 | |
|
|
Series B | •••••• | Jan 2025 |
|
|
Series C | •••••• | Mar 2024 |
|
|
Series C | •••••• | Feb 2024 |
|
|
Series A | •••••• | Jan 2024 |
|
|
Series C | •••••• | Jan 2024 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.